Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07224555 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning Hair

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 2026 to Dec 2026
    • Study completion date: Jun 2026 to Mar 2027
    v4
  2. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised at 4 of 4 sites
    v3
  3. Site contacts updated at 1 of 4 sites
    • Study title shortened, about 7 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in women with self-perceived thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 5 visits after voluntary consent has been given. Participants will be given a 30-day supply of the gummies at each visit over a 4-month period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.
Trial Details
NCT Number NCT07224555
Lead Sponsor Restore Biologics Holdings, Inc. dba Xtressé
Conditions
(from sponsor)		 Hair Thinning
Related terms Alopecia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov